O-1602
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


O-1602
Description:
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.Stability:
≥ 2 yearsPurity:
>98% (HPLC)Weight:
258.36Molecular Formula:
C17H22O2Notes:
Research use only, not for human use.Receptor:
Calcium Channel | Cannabinoid ReceptorCAS Number:
317321-41-8
